JOHNSON & JOHNSON
- CORRECTED-UPDATE 1-Achillion partners with J&J to develop hep C drugs (May 19) Reuters - Sectors - Healthcare
- Achillion partners with J&J to develop hepatitis C drugs Reuters - Markets - Deals
- Johnson & Johnson agrees to pay $7.8M to settle lawsuit The Stuttgart Daily Leader - News - Stuttgart, AR
- IBM Pulls Apple, J&J Into Watson Health Data Alliance Investor's Business Daily Technology News
- Depomed wraps up $1.05B acquisition of rights to Janssen franchise Biotechnology Industry Organization BIO SmartBrief
- Depomed acquires US rights to Nucynta franchise for $1.05bn from Janssen Pharmaceutical Business Review
- Johnson & Johnson, GSK settle dispute over OTC advertising claims Medical Marketing and Media
- Philips and Janssen partner to develop new handheld blood test Medical Devices Business Review
- J&J Wins Battle Over Concerta Patent Ownership Law 360 Intellectual Property
- Janssen Pharmaceuticals buys English biopharma company The NJBIZ - News
Alerts on more than 5,000 companies today, including:
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on JOHNSON & JOHNSON
- Rate JOHNSON & JOHNSON on their payment behavior
- Ask your network about JOHNSON & JOHNSON with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.